Nijhout HF, Reed MC, Lam S-L, Gregory JF, Shane B, Ulrich CM: In silico experimentation with a model of hepatic mitochondrial folate metabolism
Thats a user population that includes not only weight lifters and bodybuilders but also people at risk for: Sarcopenia The worldwide prevalence of sarcopenia, or age-related muscle loss, is 10-16%, so its far from uncommon.31 And because people begin to lose 3-8% of their existing muscle mass with every proceeding decade of adult life, it behooves you to take active measures to preserve the lean mass you have.32 Otherwise, you may find yourself struggling with physical weakness and decreased physiological function as you grow older.33 Resistance training can mitigate the risk, and a growth hormone secretagogue peptide can support your resistance training
L-Carnitine plays a role in transporting fat into your cells to be used as energy
Those who should be considered for this Low Dose Naltrexone therapy include the elderly, those who are immunocompromised, and those who have structural lung disease.